Description
8-Bromoquinoline-4-carbonitrile (CAS No. 1190315-89-9) is a high-purity brominated quinoline derivative with the molecular formula C10H5BrN2. This compound features a quinoline core substituted with a bromine atom at the 8-position and a cyano group at the 4-position, making it a versatile intermediate for organic synthesis and pharmaceutical research. It is supplied as a crystalline solid with ≥95% purity (HPLC), ensuring optimal performance in demanding applications. Suitable for use in cross-coupling reactions, heterocyclic chemistry, and as a building block for drug discovery, this product is rigorously tested for quality and consistency. Store in a cool, dry place under inert conditions to maintain stability.
Properties
- CAS Number: 1190315-89-9
- Complexity: 232
- IUPAC Name: 8-bromoquinoline-4-carbonitrile
- InChI: InChI=1S/C10H5BrN2/c11-9-3-1-2-8-7(6-12)4-5-13-10(8)9/h1-5H
- InChI Key: UCDBLYHPJMMFMY-UHFFFAOYSA-N
- Exact Mass: 231.96361
- Molecular Formula: C10H5BrN2
- Molecular Weight: 233.06
- SMILES: C1=CC2=C(C=CN=C2C(=C1)Br)C#N
- Topological: 36.7
- Monoisotopic Mass: 231.96361
- Synonyms: 8-bromoquinoline-4-carbonitrile, 1190315-89-9, 8-bromoquinoline- 4-carbonitrile, MFCD12024578, 8-Bromo-4-cyanoquinoline, DTXSID70676539, AKOS015834723, DB-061481, CS-0442103
Application
8-Bromoquinoline-4-carbonitrile is widely used as a key intermediate in the synthesis of bioactive quinoline derivatives, particularly in pharmaceutical and agrochemical research. It serves as a precursor for palladium-catalyzed cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, enabling the construction of complex heterocyclic scaffolds. Researchers also employ it in the development of fluorescent probes and coordination chemistry due to its electron-deficient quinoline core.
If you are interested or have any questions, please contact us at support@atomfair.com
Disclaimer: Sold exclusively for laboratory research. Prohibited for commercial use, diagnostics, or human/animal applications. Buyers assume all compliance liability.


Reviews
There are no reviews yet.